ChiCTR2200061771 版本V1.6 版本创建时间2023/03/26 19:56:21 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200061771 

最近更新日期:

Date of Last Refreshed on:

2022-08-30 02:54:20 

注册时间:

Date of Registration:

2022-07-02 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

基于格林模式的社区健康教育对兰州市社区空巢老年糖尿病患者自我管理的干预研究

Public title:

Intervention Study of Community Health Education Based on PRECEDE-PROCEED Model on Self-Management of Empty Nest Patients with diabetes in Lanzhou Community

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于格林模式的社区健康教育对兰州市社区空巢老年糖尿病患者自我管理的干预研究

Scientific title:

Intervention Study of Community Health Education Based on PRECEDE-PROCEED Model on Self-Management of Empty Nest Patients with diabetes in Lanzhou Community

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

郭少凡 

研究负责人:

李芳 

Applicant:

Guo Shaofan 

Study leader:

Li Fang 

申请注册联系人电话:

Applicant telephone:

+86 18809424130

研究负责人电话:

Study leader's
telephone:

+86 13893379669

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

gsfannnnnn@gmail.com

研究负责人电子邮件:

Study leader's E-mail:

2862422633@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

甘肃省兰州市城关区定西东路35号甘肃中医药大学

研究负责人通讯地址:

甘肃省兰州市城关区定西东路35号甘肃中医药大学

Applicant address:

35 Dingxi Road East, Lanzhou, Gansu, China

Study leader's address:

35 Dingxi Road East, Lanzhou, Gansu, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

甘肃中医药大学

Applicant's institution:

Gansu University of Chinese Medicine

研究负责人所在单位:

甘肃中医药大学

Affiliation of the Leader:

Gansu University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2020022

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

甘肃中医药大学护理学院伦理委员会

Name of the ethic committee:

Ethics Committee of School Nursing at Gansu University of Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2020-05-24 00:00:00

伦理委员会联系人:

崔宇红

Contact Name of the ethic committee:

Yuhong Cui

伦理委员会联系地址:

甘肃省兰州市城关区定西东路35号甘肃中医药大学护理学院

Contact Address of the ethic committee:

35 Dingxi Road East, Lanzhou, Gansu, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

甘肃中医药大学

Primary sponsor:

Gansu University of Chinese Medicine

研究实施负责(组长)单位地址:

甘肃省兰州市城关区定西东路35号

Primary sponsor's address:

35 Dingxi Road East, Lanzhou, Gansu, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

甘肃

市(区县):

兰州

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

甘肃中医药大学

具体地址:

甘肃省兰州市城关区定西东路35号

Institution
hospital:

Gansu University of Chinese Medicine

Address:

35 Dingxi Road East, Lanzhou, Gansu, China

经费或物资来源:

Source(s) of funding:

No funding

研究疾病:

2型糖尿病  

Target disease:

type2 diabetes

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究以格林模式理论框架为指导,制定并实施有针对性的社区健康教育,并对干预效果进行评价,以期提高兰州市社区空巢老年糖尿病患者自我管理能力,改善患者的血糖控制水平,延缓或避免糖尿病并发症的发生。  

Objectives of Study:

This study develops and implements targeted community health education and evaluates the effect of intervention, with a view to improving the self-management ability of the elderly diabetic patients with empty nest in Lanzhou, improving the blood sugar control level of the patients, and delaying or avoiding the occurrence of diabetes complications.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄≥60周岁且为兰州市社区常住居民;
2.无子女、保姆照顾,一人独居或夫妻同住。
3.意识清楚,精神、认知功能正常,沟通无障碍。

Inclusion criteria

1. Aged over 60 years and permanent resident of the Lanzhou community;
2. No children, nanny care, one person living alone or husband and wife living together.
3. Clear consciousness, normal mental and cognitive function, and no communication impediments.

排除标准:

1. 合并糖尿病严重并发症;
2. 因各种原因导致身体状况较差者、卧床甚至行动不便者。

Exclusion criteria:

1. With severe complications of diabetes mellitus;
2. Poor physical condition, bedridden and even inconvenient for various reasons.

研究实施时间:

Study execute time:

From 2020-05-01 00:00:00 To 2020-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-05-01 00:00:00 To 2020-05-31 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

50

Group:

intervention group

Sample size:

干预措施:

基于格林模式的社区健康教育

干预措施代码:

Intervention:

Health Education Based on PRECEDE-PROCEED Model

Intervention code:

组别:

对照组

样本量:

50

Group:

control group

Sample size:

干预措施:

常规社区健康教育

干预措施代码:

Intervention:

General Community Health Education

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

甘肃 

市(区县):

兰州 

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

社区卫生服务中心 

单位级别:

社区卫生服务中心 

Institution
hospital:

community health service center

Level of the institution:

Community health service center

测量指标:

Outcomes:

指标中文名:

糖化血红蛋白

指标类型:

主要指标

Outcome:

Hemoglobin A1c

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

空腹血糖

指标类型:

主要指标

Outcome:

fasting plasma glucose

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

2小时餐后血糖

指标类型:

主要指标

Outcome:

2-hour postprandial blood glucose

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血压

指标类型:

主要指标

Outcome:

blood pressure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体质指数

指标类型:

主要指标

Outcome:

body mass index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

知行信量表得分

指标类型:

次要指标

Outcome:

the scores in knowledge-attitude-behavior

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age 82 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

按照经济水平将兰州市五个区进行排序产生2个集群(高经济水平区、低经济水平区)。第三个评估员利用随机数字表法随机在2个集群中选择2个区域,使用相同的方法在每个区域中各选择1个社区作为试验组和对照组。通过横幅或通知进行招募研究对象,研究者可根据纳入和排除标准筛选他们,以确定是否有资格参加,最终每组随机分配50名患者,他们自愿加入并签署知情同意书,但研究开始之前不知道他们将被分配到哪一组。

Randomization Procedure (please state who generates the random number sequence and by what method):

According to the economic level, the five districts of Lanzhou are sorted into two clusters (high economic level area, low economic level area). An evaluator randomly selected 2 areas in 2 clusters using the random number table method, using the same method to select 1 community in each area as the&

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Not stated

Blinding:

Not stated

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

可通过邮件形式联系项目成员获取,邮箱:gsfannnnnn@gmail.com

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

contact with our study participates by email.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

研究者自行采集管理数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Researchers collect and management data.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2022-07-02 20:57:15